Heart podcast

Heart podcast

By BMJ GroupScience
Download on the App Store

Heart podcast episodes

  • Endothelial function in contemporary patients with repaired coarctation of aorta
    Some studies have suggested endothelial dysfunction in adult patients after repair of aortic coarctation (CoA), and it has been proposed to play a key role in the pathogenesis of arterial hypertension in the absence of re-coarctation.
    A study recently published in Heart aimed to assess the presence of endothelial dysfunction, the number of endothelial progenitor cells, and the levels of proinflammatory cytokines associated with endothelial injury in contemporary patients after CoA repair.
    Alistair Lindsay discusses what the work revealed with lead author Robert Radke, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiology and Angiology, University Hospital Muenster.
    Read the full paper (for free):
    http://goo.gl/z32cOl
    13 min
  • New ESC Guidelines for aortic disease
    The ESC has published new guidelines for diagnosis and management of thoracic aortic disease.
    In this podcast, Catherine Otto asks Dr Iung, Professor of Cardiology, Bichat Hopital, Paris Diderot University, France, to summarise the key new points in these guidelines, specifically focusing on aortopathy in patients with bicuspid valve disease, and in those with Marfan syndrome and other inherited connective tissue disorders.
    This podcast was recorded at the European Society of Cardiology Annual Scientific Sessions, Barcelona, Spain, August 2014.
    6 min
  • Primary prevention of cardiovascular disease in children and young adults
    In this episode of the Heart podcast, Dr James Rudd, associate editor, sits down to talk with Prof Valentin Fuster, director of Mount Sinai Heart and physician-in-chief at The Mount Sinai Medical Center in New York, at the ESC meeting in Barcelona.
    They discuss his ground-breaking work in the primary prevention of cardiovascular disease in children and young adults across the world and the role of imaging in identifying early heart disease. Prof. Fuster also explains the rationale behind the polypill and how he came to have his own character on Sesame Street.
    13 min
  • Risk models for pregnant women with congenital heart disease
    In this podcast Catherine Otto speaks to Dr P G Pieper, Associate Professor of Cardiology, University Medical Center Groningen, the Netherlands, about the recent paper in Heart on assessing the risk of pregnancy for women with congenital heart disease.
    This study compared three different scoring systems and found that the WHO score provided the most accurate risk prediction. The importance of this issue is illustrated by the approximately 10% risk of maternal complications in this patient group.
    This podcast was recorded at the European Society of Cardiology Annual Scientific Sessions, Barcelona Spain, August 31, 2014.
    Read the original article:
    Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease http://heart.bmj.com/content/100/17/1373
    11 min
  • "Is climbing Everest good for my heart, doctor?"
    Recorded at the 2014 British Cardiovascular Society meeting in Manchester, Heart associate editor Dr James Rudd talks to Dr Rob Casserley, summiteer of Everest, and his wife and cardiologist Marie-Kristelle Ross.
    Rob initially worked as surgeon and is now a GP with a specialist interest in altitude and expedition medicine. He has climbed Everest eight times, including double summits in spring 2007 and spring 2010, and is the first-ever Western climber to have achieved this feat. He was been featured in "Everest ER", a BBC1 documentary series about medicine and climbing on Everest. He assisted Sir Ranulph Fiennes as doctor, guide and cameraman in a 2008 climb of Everest.
    In this episode of the Heart podcast, they discuss high altitude, endurance sports and their effects on the heart and lungs in both health and disease.
    22 min
  • Patient selection for transcatheter aortic valve implantation
    Professor Vahanian, Bichat Hospital, Paris, France, is a world leader in management of patients with Valvular Heart Disease and is the lead author of the European Society of Cardiology Guidelines. In this interview, held during the Transcatheter Valve Therapeutics Meeting in Vancouver, Canada in June 2014, Professor Vahanian talks with Catherine Otto about the current approach to patient selection for transcatheter aortic valve implantation (TAVI).
    The availability of TAVI has transformed our approach to the elderly or high risk patient with severe aortic stenosis and the use of this technology continues to expand as technical issues are resolved and more data on valve durability is published.
    Clinicians will want to keep up to date on the latest information so appropriate patients are referred for this life saving treatment.
    To read more about transcatheter aortic valve implantation, see several recent articles in Heart:
    Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score http://goo.gl/lcflnl
    Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry http://goo.gl/WkfmM5
    Aortic regurgitation severity after transcatheter aortic valve implantation is underestimated by echocardiography compared with MRI http://goo.gl/KIo6B4
    Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation http://goo.gl/YTcbaf
    Original article: Device-dependent association between paravalvar aortic regurgitation and outcome after TAVI http://goo.gl/u5dK82
    7 min
  • Transcatheter mitral valve repair: which patients benefit?
    In this interview held during the Transcatheter Valve Therapeutics Meeting in Vancouver, Canada in June 2014, Heart editor Catherine Otto talks to Ted Feldman, Evanston Hospital.
    Professor Feldman is one of the leaders in the field of transcatheter mitral valve repair, and discusses patient selection, procedural aspects and intermediate term outcomes with this exciting new therapy.
    Clinicians will find this brief summary useful as this new technique offers a therapeutic options for many of our patients with mitral regurgitation who are not candidates for conventional open surgery.
    For more information about intervention for patients with severe mitral regurgitation, readers can consult several recent articles in Heart:
    A systematic review on the safety and efficacy of percutaneous edge-to-edge mitral valve repair with the MitraClip system for high surgical risk candidates http://goo.gl/0MBpMF
    2014 ACC/AHA valve guidelines: earlier intervention for chronic mitral regurgitation http://goo.gl/dXDX0U
    Valvular heart disease: The evolving role of multimodality imaging in valvular heart disease http://goo.gl/IcJdqW
    Almanac 2013: Novel non-coronary cardiac interventions http://goo.gl/OpoHGC
    Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry http://goo.gl/DqHBAi
    12 min
  • Cardiac Electrophysiology in 2014
    Recorded at the 2014 British Cardiovascular Society meeting in Manchester, Heart associate editor Dr James Rudd talks to Dr Arthur Yue, consultant electrophysiologist at the University Hospital of Southampton.
    In this podcast, they discuss the expanding roles of electrophysiological specialists in managing arrhythmias, accessory pathways and the new upcoming NICE guidelines on atrial fibrillation.
    16 min

About Heart podcast

From the publisher's feed

From June 2023, all our podcasts will move to https://heartbmj.podbean.com.